• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[镰刀菌酸盐酸β-(N,N-二乙氨基)乙酯、奥布齐丹和阿替洛尔在实验性肾上腺素诱导的心律失常中的比较疗效]

[Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].

作者信息

Savina M D

出版信息

Farmakol Toksikol. 1986 May-Jun;49(3):47-50.

PMID:3720934
Abstract

Hydrochloride beta-(N,N-diethylamino)ethylamide of fusaric acid (DAEA) exerted an antiarrhythmic activity in adrenaline-induced arrhythmia in rats. DAEA single pretreatment in doses of 1-5 mg/kg prevented the disorders of rhythm and conductivity in most animals. A pronounced antiarrhythmic effect was manifest at doses of 2 and 4 mg/kg of DAEA. The comparison of efficacy of DAEA, obzidan and atenolol showed that atenolol exhibited only a low antiarrhythmic activity, DAEA prevented the development of arrhythmia in 50% of animals in a dose of 1.7 mg/kg (1/42 of LD50) and obzidan--1 mg/kg (1/40 of LD50), respectively. The antiarrhythmic effect of DAEA was not followed by marked suppression of cardiac conductivity.

摘要

富马酸β-(N,N-二乙氨基)乙酰胺盐酸盐(DAEA)对大鼠肾上腺素诱发的心律失常具有抗心律失常活性。剂量为1-5mg/kg的DAEA单次预处理可预防大多数动物的节律和传导紊乱。在DAEA剂量为2和4mg/kg时,表现出明显的抗心律失常作用。DAEA、奥齐丹和阿替洛尔疗效比较表明,阿替洛尔仅表现出低抗心律失常活性,DAEA剂量为1.7mg/kg(LD50的1/42)时可预防50%动物发生心律失常,奥齐丹——剂量为1mg/kg(LD50的1/40)时可预防50%动物发生心律失常。DAEA的抗心律失常作用并未伴随明显的心脏传导抑制。

相似文献

1
[Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].[镰刀菌酸盐酸β-(N,N-二乙氨基)乙酯、奥布齐丹和阿替洛尔在实验性肾上腺素诱导的心律失常中的比较疗效]
Farmakol Toksikol. 1986 May-Jun;49(3):47-50.
2
[Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].[与新斯的明相比,富马酸 N,N-二乙氨基乙酯在实验性心律失常模型中的抗心律失常活性]
Farmakol Toksikol. 1982 Mar-Apr;45(2):63-5.
3
[Antiarrhythmic activity of alaglyzin].
Eksp Klin Farmakol. 2005 Jul-Aug;68(4):24-7.
4
[The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].[红景天提取物及对羟基苯乙醇在实验性心律失常模型中的抗心律失常作用]
Eksp Klin Farmakol. 1998 Mar-Apr;61(2):37-40.
5
Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.2-(正戊氧基)羰基苯胺的1-甲氧基甲基-2-(1-全氢氮杂环庚烷基)乙酯盐酸盐的抗心律失常活性
Arzneimittelforschung. 1987 Feb;37(2):149-52.
6
The effect of ethanol on the antiarrhythmic action of atenolol.乙醇对阿替洛尔抗心律失常作用的影响。
Pol J Pharmacol Pharm. 1989 May-Jun;41(3):207-11.
7
[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands].[西格玛受体配体的抗心律失常及促心律失常特性]
Eksp Klin Farmakol. 2000 Mar-Apr;63(2):39-43.
8
[Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].[氯化钙诱导小鼠心律失常模型中抗心律失常药物活性的比较研究]
Farmakol Toksikol. 1983 May-Jun;46(3):48-50.
9
[The effect of naloxone on rhythm disorders and on the conduction system of the heart].[纳洛酮对心律失常及心脏传导系统的影响]
Eksp Klin Farmakol. 1996 May-Jun;59(3):34-6.
10
[The anti-arrhythmia activity of quinazopyrine].[喹唑并吡啶的抗心律失常活性]
Farmakol Toksikol. 1990 May-Jun;53(3):15-7.